Literature DB >> 15772777

C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.

Tetsu Watanabe1, Yasuchika Takeishi, Osamu Hirono, Makoto Itoh, Motoyuki Matsui, Kazuharu Nakamura, Yoshiaki Tamada, Isao Kubota.   

Abstract

It has been poorly understood whether inflammation may contribute to atrial structural remodeling and increase the propensity for atrial fibrillation (AF) to persist. We investigated the relationship between C-reactive protein (CRP) elevation and the development of atrial remodeling in AF. The study population comprised 50 consecutive paroxysmal AF (PAF) patients and 50 control patients without AF. All patients underwent echocardiography, and high-sensitivity CRP was routinely measured. C-Reactive protein was significantly higher in the patients with PAF than control patients (0.231+/-0.176 mg/dl vs 0.055+/-0.041 mg/dl, P<0.001). Other predictors of elevated CRP included left ventricular mass (P<0.05), left ventricular end-systolic diameter (P<0.05), and left atrial (LA) diameter (P<0.001). In a multivariate analysis, only CRP and LA diameter were independent predictors of PAF. Elevated CRP levels correlated with LA diameter (r=0.489, P<0.001). Left atrial diameter was increased in PAF patients compared with control patients (P<0.001). We found that a longer duration of AF is associated with higher CRP levels and a larger LA diameter (duration <30 days: CRP 0.166+/-0.139 mg/dl, LA diameter 38.4+/-8.0 mm; duration >30 days: CRP 0.345+/-0.181 mg/dl, LA diameter 45.6+/-6.6 mm; P<0.001). In conclusion, longer AF duration is associated with CRP elevation and atrial structural remodeling, as approximated by larger LA diameter. However, CRP elevation, while correlating with LA diameter, was not an independent predictor of atrial structural remodeling. Thus, it remains unclear whether CRP and the inflammatory state are contributory to LA remodeling or whether LA remodeling or AF induces elevation in CRP and inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772777     DOI: 10.1007/s00380-004-0800-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Left atrial epicardial adiposity and atrial fibrillation.

Authors:  Omar Batal; Paul Schoenhagen; Mingyuan Shao; Ala Eddin Ayyad; David R Van Wagoner; Sandra S Halliburton; Patrick J Tchou; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-05-26

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset.

Authors:  Pier Luigi Pellegrino; Natale Daniele Brunetti; Luisa De Gennaro; Luigi Ziccardi; Massimo Grimaldi; Matteo Di Biase
Journal:  Intern Emerg Med       Date:  2011-03-30       Impact factor: 3.397

4.  Interleukin-37 elevation in patients with atrial fibrillation.

Authors:  Weidong Li; Shijie Li; Xianjin Li; Shuzhong Jiang; Bing Han
Journal:  Clin Cardiol       Date:  2016-11-02       Impact factor: 2.882

Review 5.  Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data.

Authors:  Karen P Phillips
Journal:  J Atr Fibrillation       Date:  2013-10-31

Review 6.  Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients.

Authors:  Louiza Lioni; Panagiotis Korantzopoulos; Konstantinos P Letsas
Journal:  J Atr Fibrillation       Date:  2011-12-20

Review 7.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

8.  Atrial fibrillation and inflammation.

Authors:  Mehmet Ozaydin
Journal:  World J Cardiol       Date:  2010-08-26

Review 9.  Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Authors:  Hadi Ar Hadi; Wael Al Mahmeed; Jassim Al Suwaidi; Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

10.  Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.

Authors:  Rafik R Anis
Journal:  Exp Clin Cardiol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.